profit from every $100 of sales.
$0$100
Boston Scientific
$44.34+0.32% today
-57.8% in 1 year
1-year low $41.581-year high $104.98
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2020 to 2025.
0%20% a year
You pay $22.18 for every $1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Boston Scientific sold, what it kept, and what it did with the cash.
Sales went from $12.7 billion in 2022 to $20.1 billion in 2025, with $2.90 billion of profit last year.
SalesProfit
Boston Scientific vs. similar companies
Boston Scientific grows in the middle of these 5 and is the cheapest for its profits.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Boston Scientific | 22.2× · Fair price | ||
 Koninklijke Philips | 30.1× · Expensive | ||
 Steris | 32.8× · Expensive | ||
 Zimmer Biomet Holdings | 27.7× · Fair price | ||
 Glaukos | No profit yet |
Compare Boston Scientific with AbbVie · Johnson & Johnson · Eli Lilly · 3M · Roche · Stryker · UnitedHealth
AI analysis
Boston Scientific grows fast, but the share price already assumes plenty
Read the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 9,913 | 11,888 | 12,682 | 14,240 | 16,747 | 20,074 | |
| 6,448 | 8,177 | 8,727 | 9,895 | 11,490 | 13,853 | |
| – | – | 2,034 | 2,417 | 3,002 | 3,971 | |
| 1,405 | 2,510 | 2,747 | 3,446 | 3,856 | 5,102 | |
| -82 | 1,041 | 698 | 1,593 | 1,854 | 2,898 | |
| -0.08 | 0.69 | 0.45 | 1.07 | 1.25 | 1.94 | |
| 65.0% | 68.8% | 68.8% | 69.5% | 68.6% | 69.0% | |
| – | – | 16.0% | 17.0% | 17.9% | 19.8% | |
| -0.8% | 8.8% | 5.5% | 11.2% | 11.1% | 14.4% |
Balance sheet
| In millions of USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Total assets | 30,777 | 32,229 | 32,469 | 35,136 | 39,395 | 43,673 |
| Cash | 1,734 | 1,925 | 928 | 865 | 414 | 1,965 |
| Total debt | 9,143 | 9,065 | 9,282 | 9,492 | 10,746 | 11,436 |
| Total liabilities | – | – | 14,896 | 15,606 | 17,392 | 19,201 |
| – | 16,622 | 17,574 | 19,281 | 21,770 | 24,232 | |
| 1,417 | 1,434 | 1,440 | 1,464 | 1,486 | 1,495 | |
| – | 4.4% | 4.7% | 6.2% | 6.3% | 8.3% | |
| – | 6.3% | 4.0% | 8.3% | 8.5% | 12.0% |
Cash flow
| In millions of USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 1,508 | 1,870 | 1,526 | 2,503 | 3,435 | 4,534 | |
| – | – | 612 | 800 | 1,070 | 1,130 | |
| – | – | 914 | 1,703 | 2,365 | 3,404 | |
| Dividends paid | 28 | 55 | 55 | 28 | 0 | – |
| 535 | 0 | 0 | – | – | – | |
| 170 | 194 | 220 | 233 | 266 | 299 |
Valuation
- 22.2×
- 13.1×
- –
- 2.8×
- 3.2×
- 18.9×
- 14.5×
- 5.3%
- 4.5%
- 0.0%
Profitability
- 69.0%
- 19.8%
- 14.4%
- 23.1%
- 9.9%
- 5.1%
- 14.8%
- 8.0%
- 10.4%
- 10.3%
Growth
- +15.2%
- –
- +38.3%
- –
- +1.0%
Financial health
- 2.0×
- 0.43
- 24.9%
- 11.6×
- 1.90
- 1.22
- 0.46
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 30%of 952
Top 24%of 883
Top 41%of 601
Top 35%of 888
Top 21%of 987
What analysts expect
- Average price target
- $91.33
- Range
- $60.00 – $120.00
- 29 analysts
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| Apr 22, 2026 | 0.80 | 0.79 | +1.5% |
| Feb 4, 2026 | 0.80 | 0.78 | +2.4% |
| Oct 22, 2025 | 0.75 | 0.71 | +5.0% |
| Jul 23, 2025 | 0.75 | 0.73 | +3.4% |
| Apr 23, 2025 | 0.75 | 0.67 | +11.4% |
| Feb 5, 2025 | 0.70 | 0.66 | +6.5% |
| Oct 23, 2024 | 0.63 | 0.59 | +7.1% |
| Jul 24, 2024 | 0.62 | 0.58 | +6.3% |
News
Can Boston Scientific Stock Bounce Off This Support Again?Yahoo Finance · Oct 22, 2026Famed former Boston Celtics commentator lists sunny Boston penthouse for $1.5 millionMarketWatch · Oct 2, 2026Boston Omaha replaces buyback plan with new $30M programSeeking Alpha · Sep 11, 2026Boston Scientific (BSX) Stock Declines While Market Improves: Some Information for InvestorsYahoo Finance · Sep 3, 2026Notable healthcare headlines for the week: Veeva Systems, Boston Scientific in focusSeeking Alpha · Aug 30, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
2/7Passes 2 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
59No pass
Benjamin Graham
54No pass
Philip Fisher
63Pass
Peter Lynch
73Pass
Joel Greenblatt
27No pass
Charlie Munger
49No pass
Terry Smith
54No pass
Questions about Boston Scientific
Is Boston Scientific a good stock to buy?
A solid business at a fair price. 2 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Boston Scientific AI analysis
What does Boston Scientific do?
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. It is in Medical - Devices, based in Marlborough, MA, United States, with 59,000 employees.
Does Boston Scientific pay a dividend?
No. Boston Scientific does not pay a dividend at the moment.
Is Boston Scientific stock halal?
Yes. Boston Scientific passes our halal screen: its business is permitted and its debt is 18% of its market value, under the 30% limit. How we check
How has Boston Scientific stock done over the past year?
Down 57.8% over the past twelve months, to $44.34. It traded between $41.58 and $104.98 and is 57.8% below its high.
Who are Boston Scientific's competitors?
The largest listed companies in the same industry are Koninklijke Philips, Steris, Zimmer Biomet Holdings and Glaukos. The peers table on this page compares their profit, growth and price with Boston Scientific's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.